Allergan Improves Safety Of Abicipar, But Not Enough Compared To Lucentis, Eylea

 
• By Joseph Haas
  
Medical photo Age-related macular degeneration (AMD)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D